Stem cell therapy for acute toxic hepatitis
Stem cell therapy offers promising prospects for treating acute toxic hepatitis, a severe liver condition. By analyzing preclinical studies, this article explores the mechanisms of action, safety, and efficacy of stem cell-based interventions. The findings suggest that stem cells can mitigate liver damage, reduce inflammation, and promote tissue regeneration, highlighting their potential as a novel therapeutic approach for acute toxic hepatitis.














